What LifeMD, Inc. Shareholders Need to Understand About the Class Action Lawsuit

Understanding Your Rights as a LifeMD, Inc. Shareholder

As a shareholder of LifeMD, Inc. (NASDAQ: LFMD), it's crucial to stay informed about ongoing legal matters that may impact your investments. Recently, a class action securities lawsuit has been filed by Levi & Korsinsky, LLP, aimed at securing justice for investors who may have suffered losses due to alleged securities fraud during a critical period from May 7, 2025, to August 5, 2025.

The Allegations

The core of the lawsuit revolves around claims that LifeMD, Inc. misrepresented its financial health and operational capacity. According to the filed complaints, the defendants are accused of making false statements regarding the company’s competitive position and its 2025 guidance. This alleged misinformation is said to have failed to account adequately for rising customer acquisition costs, particularly in the RexMD segment and for drugs aimed at treating obesity, like Wegovy and Zepbound.

The plaintiffs argue that these oversights led to materially misleading statements about LifeMD's business operations and future prospects, which ultimately had a negative impact on shareholder value. This lawsuit seeks not only to recover financial losses but also to bring transparency and accountability to the company's disclosures.

What Should Shareholders Do?

Affected investors have until October 27, 2025, to make their voices heard. It's advisable for those who believe they belong to this class to contact Levi & Korsinsky, LLP, to seek more information on how to file a claim and potentially serve as a lead plaintiff. Notably, your participation as a class member does not require you to take on the lead role; you may still be entitled to compensation regardless of your level of involvement in the case.

No Cost to Participate

One of the significant advantages of engaging with this class action is that involved shareholders may not bear any out-of-pocket costs or obligations. By being a part of this class, shareholders can seek compensation without upfront financial burdens, which makes it accessible for many investors who may otherwise hesitate to pursue such a legal route.

Why Choose Levi & Korsinsky?

With over 20 years of experience in film partners have recovered hundreds of millions in settlements for aggrieved shareholders across various lawsuits. Levi & Korsinsky has established a robust reputation for representing investors in complex litigation, boasting a dedicated team of over 70 professionals to assist clients effectively. Their track record is evidenced by the fact that they have ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years.

Contacting Levi & Korsinsky

If you are a shareholder of LifeMD and have concerns regarding your investment or the ongoing lawsuit, you can contact Joseph E. Levi, Esq., or Ed Korsinsky, Esq., directly. Their office is located at 33 Whitehall Street, 17th Floor, New York, NY 10004, and can be reached via email at [email protected] or by phone at (212) 363-7500. They also provide an online submission form where investors can express interest and receive further assistance regarding the lawsuit.

Conclusion

The class action lawsuit against LifeMD, Inc. introduces a vital opportunity for affected investors to regain losses incurred during the specified time frame. Staying proactive and informed about legal developments can dramatically affect the outcome for shareholders. Engaging with legal experts like Levi & Korsinsky allows investors to secure their rights and work towards achieving the best possible resolution to this situation.